Name: Nippon India Pharma Fund Direct Bonus
Brand: Nippon India Mutual Fund

Home>Mutual Funds>Nippon India Mutual Fund>Nippon India Pharma Fund Direct Bonus

bookmark_border
share
Nippon India Pharma Fund Direct Bonus
Equity
Sectoral / Thematic
Very High Risk
43.97%
1Y return
-1.45% 1D
1M
6M
1Y
3Y
5Y
All
 NAV: 24 Sep 2021₹334.62
Min. SIP amountNA
Rating5star
Fund size₹5,667.10 Cr
Understand termsAnnualised returnsAverage of the yearly returns of a mutual fund over a given period.
Absolute returnsThe total return of a mutual fund over a given period.
Returns and rankingsCategory: Equity Sectoral / Thematic
Annualised returns
Absolute returns
1Y3Y5YAll
Fund returns44.0%26.1%17.2%19.6%
Category average58.4%28.2%13.5%NA
Rank with in category241NA
Understand termsinfo
Holdings (23)NameSectorInstrumentAssets
Sun Pharmaceutical Industries Ltd.
HealthcareEquity10.7%
Divi's Laboratories Ltd.
HealthcareEquity10.0%
Dr. Reddy's Laboratories Ltd.
HealthcareEquity8.3%
Apollo Hospitals Enterprise Ltd.
HealthcareEquity6.8%
Cipla Ltd.
HealthcareEquity6.7%
Gland Pharma Ltd.
HealthcareEquity5.8%
Aurobindo Pharma Ltd.
HealthcareEquity5.8%
Lupin Ltd.
HealthcareEquity5.8%
Fortis Healthcare Ltd.
HealthcareEquity5.4%
Narayana Hrudayalaya Ltd.
HealthcareEquity4.7%
See All
DisclaimerThis content is derived from publicly available information, internal sources, and other third-party sources believed to be reliable. We, at Nextbillion Technology Pvt. Ltd. (Groww), do not guarantee the accuracy of such information, or assure its completeness, or warrant that such information will not be changed.
All comparisons are done with the category average metrics for this category.
Pros and consinfo
Category: Equity Sectoral / Thematic
thumb_up_altPros
5Y Returns are higher than the category average returns
thumb_down_altCons
1Y Returns are lower than the category average returns
3Y Returns are lower than the category average returns
Understand termsExpense ratioA fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company’s fund assets used for administrative, management, advertising, and other expenses.
TaxA percentage of your capital gains payable to the government upon exiting your mutual fund investments. Taxation is categorized as long-term capital gains (LTCG) and short-term capital gains (STCG) depending on your holding period and the type of fund.
Exit loadA fee payable to a mutual fund house for exiting a fund (fully or partially) before the completion of a specified period from the date of investment.
Stamp dutyA form of tax payable for the purchase or sale of an asset or security. 
Past expense ratio & exit load
Expense ratio
Exit load
31 Aug 2021 - Present
1.14%
31 Jul 2021 - 31 Aug 2021
1.14%
30 Jun 2021 - 31 Jul 2021
1.16%
31 May 2021 - 30 Jun 2021
1.10%
30 Apr 2021 - 31 May 2021
0.80%
31 Mar 2021 - 30 Apr 2021
0.82%
28 Feb 2021 - 31 Mar 2021
1.04%
31 Jan 2021 - 28 Feb 2021
1.04%
31 Dec 2020 - 31 Jan 2021
1.05%
30 Nov 2020 - 31 Dec 2020
1.32%
31 Oct 2020 - 30 Nov 2020
1.15%
30 Sep 2020 - 31 Oct 2020
1.16%
31 Aug 2020 - 30 Sep 2020
1.31%
31 Jul 2020 - 31 Aug 2020
1.32%
30 Jun 2020 - 31 Jul 2020
1.35%
31 May 2020 - 30 Jun 2020
1.29%
30 Apr 2020 - 31 May 2020
1.30%
31 Mar 2020 - 30 Apr 2020
1.18%
29 Feb 2020 - 31 Mar 2020
1.21%
31 Jan 2020 - 29 Feb 2020
1.33%
31 Dec 2019 - 31 Jan 2020
1.36%
30 Nov 2019 - 31 Dec 2019
1.36%
31 Oct 2019 - 30 Nov 2019
1.36%
30 Sep 2019 - 31 Oct 2019
1.36%
31 Aug 2019 - 30 Sep 2019
1.36%
31 Jul 2019 - 31 Aug 2019
1.36%
30 Jun 2019 - 31 Jul 2019
1.36%
31 May 2019 - 30 Jun 2019
1.37%
30 Apr 2019 - 31 May 2019
1.37%
31 Mar 2019 - 30 Apr 2019
1.23%
28 Feb 2019 - 31 Mar 2019
1.23%
31 Jan 2019 - 28 Feb 2019
1.23%
31 Dec 2018 - 31 Jan 2019
1.23%
30 Nov 2018 - 31 Dec 2018
1.40%
31 Oct 2018 - 30 Nov 2018
1.40%
30 Sep 2018 - 31 Oct 2018
1.42%
31 Aug 2018 - 30 Sep 2018
1.42%
31 Jul 2018 - 31 Aug 2018
1.62%
30 Jun 2018 - 31 Jul 2018
1.63%
31 May 2018 - 30 Jun 2018
1.40%
30 Apr 2018 - 31 May 2018
1.40%
31 Mar 2018 - 30 Apr 2018
1.41%
28 Feb 2018 - 31 Mar 2018
1.40%
31 Jan 2018 - 28 Feb 2018
1.40%
31 Dec 2017 - 31 Jan 2018
1.41%
30 Nov 2017 - 31 Dec 2017
1.42%
31 Oct 2017 - 30 Nov 2017
1.43%
Expense ratio, exit load and taxExpense ratio: 1.14%Inclusive of GST
Exit loadExit load of 1% if redeemed within 1 month.
Stamp duty0.005% (from July 1st, 2020)
Tax implicationReturns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year. 
Understand termsinfo
Check past data
Minimum investment amountsMin. for 1st investmentNA
Min. for 2nd investment onwardsNA
Min. for SIPNA
Fund managementSailesh Raj Bhan
Jan 2013 - Present
View details
keyboard_arrow_down
Education
Mr. Bhan is an MBA (Finance) and CFA.
Experience
Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Also manages these schemes
Nippon India Multi Cap Fund Growth
Nippon India Multi Cap Fund Bonus
Nippon India Multi Cap Fund IDCW
Nippon India Pharma Fund Growth
Nippon India Pharma Fund Bonus
Nippon India Pharma Fund IDCW
Nippon India Consumption Fund Growth
Nippon India Consumption Fund Bonus
Nippon India Consumption Fund IDCW
Nippon India Large Cap Fund Growth
Nippon India Large Cap Fund IDCW
Nippon India Large Cap Fund Bonus
Nippon India Large Cap Fund Direct Growth
Nippon India Large Cap Fund Direct Bonus
Nippon India Large Cap Fund Direct IDCW
Nippon India Multi Cap Fund Direct Growth
Nippon India Multi Cap Fund Direct Bonus
Nippon India Multi Cap Fund Direct IDCW
Nippon India Consumption Fund Direct Bonus
Nippon India Consumption Fund Direct Growth
Nippon India Consumption Fund Direct IDCW
Nippon India Pharma Fund Direct IDCW
Nippon India Pharma Fund Direct Bonus
Nippon India Pharma Fund Direct Growth
Reliance Close Ended Equity Fund Series A Growth
Reliance Close Ended Equity Fund Series A Direct Growth
Reliance Close Ended Equity Fund Series A IDCW
Reliance Close Ended Equity Fund Series B Growth
Reliance Close Ended Equity Fund Series B Direct Growth
Reliance Close Ended Equity Fund Series B IDCW
Reliance Close Ended Equity Fund II Series A Direct Growth
Reliance Close Ended Equity Fund II Series A IDCW
Reliance Close Ended Equity Fund II Series A Growth
Nippon India India Opportunities Fund Series A Regular Growth
Nippon India India Opportunities Fund Series A Direct Growth
Nippon India India Opportunities Fund Series A Regular IDCW
Nippon India India Opportunities Fund Series A Direct IDCW
Fund house & investment objective
keyboard_arrow_down
Nippon India Mutual Fund
Rank (total assets)#6 in India
Total AUM2,30,092.13 Cr
Date of Incorporation30 Jun 1995
Nippon India Pharma Fund Direct Bonus is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors
Nippon India Pharma Fund Direct Bonus is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 30 Jun 1995. Sailesh Raj Bhan is the Current Fund Manager of Nippon India Pharma Fund Direct Bonus fund. The fund currently has an Asset Under Management(AUM) of ₹2,30,092 Cr and the Latest NAV as of 24 Sep 2021 is ₹334.62.
The Nippon India Pharma Fund Direct Bonus is rated Very High risk. Minimum SIP Investment is set to 100. Exit load of 1% if redeemed within 1 month....Read more
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated comp
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
...Read more
Fund benchmarkS&P BSE Healthcare TRI
descriptionScheme Information Document(SID)
Fund house contact details
keyboard_arrow_down
Address
Corporate Office : Reliance Centre, 7th Floor South Wing, OFf Western Express Highway, Santacruz(E) Mumbai-400055
Phone
022-33031000/30301111
Launch Date
30 Jun 1995
E-mail
[email protected]
Website
NA
Nippon India Mutual Fund
Asset Management Company
Custodian
Deutsche Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
Email
[email protected]
Website
www.karvymfs.com
Compare funds
Nippon India Pharma Fund Direct Bonus
VS
Add mutual fund to compare

No.11, 2nd floor, 80 FT Road
4th Block, S.T Bed, Koramangala
Bengaluru – 560034
Contact Us
PRODUCTS
StocksFutures & OptionsMutual FundsFixed DepositGoldUS Stocks
GROWW
About UsPricingBlogMedia & PressHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww Digest
ⓒ 2016-2021 Groww. All rights reserved, Built with ♥in India

	1Y	3Y	5Y	All
Fund returns	44.0%	26.1%	17.2%	19.6%
Category average	58.4%	28.2%	13.5%	NA
Rank with in category	2	4	1	NA

Name	Sector	Instrument	Assets
Sun Pharmaceutical Industries Ltd.	Healthcare	Equity	10.7%
Divi's Laboratories Ltd.	Healthcare	Equity	10.0%
Dr. Reddy's Laboratories Ltd.	Healthcare	Equity	8.3%
Apollo Hospitals Enterprise Ltd.	Healthcare	Equity	6.8%
Cipla Ltd.	Healthcare	Equity	6.7%
Gland Pharma Ltd.	Healthcare	Equity	5.8%
Aurobindo Pharma Ltd.	Healthcare	Equity	5.8%
Lupin Ltd.	Healthcare	Equity	5.8%
Fortis Healthcare Ltd.	Healthcare	Equity	5.4%
Narayana Hrudayalaya Ltd.	Healthcare	Equity	4.7%

Rating	5
Fund size	₹5,667.10 Cr